High costs in toxicology significantly impact the overall drug development process. They contribute to the lengthy and expensive journey from drug discovery to market. These costs often get passed down to consumers, reflected in the high prices of certain medications. Consequently, pharmaceutical companies might prioritize drugs with higher market potential, sometimes neglecting rare diseases with smaller patient populations.
